SETTLEMENT AGREEMENT AND MUTUAL RELEASESSettlement Agreement • March 27th, 2024 • Scilex Holding Co • Biological products, (no disgnostic substances) • Delaware
This Settlement Agreement and Mutual Releases (the “Agreement”) is entered into as of February 29, 2024 by and among Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals Inc., on the one hand, and Virpax Pharmaceuticals, Inc. on the other hand. They are collectively referred to herein as “the Parties” and each individually as a “Party.”
